Cart
sales@molnova.com
Anifrolumab
Anifrolumab
Catalog No. M36891
Anifrolumab（MEDI-546） is a potent type I interferon (IFN) receptor antagonist, a human monoclonal antibody that targets IFN.Anifrolumab inhibits the activity of type I interferon and is used for the prevention and treatment of systemic lupus erythematosus (SLE).
| Size | Price / USD | Stock | Quantity |
| 2MG | 299 | Get Quote |
|
| 5MG | 425 | Get Quote |
|
| 10MG | 656 | Get Quote |
|
| 25MG | 984 | Get Quote |
|
| 50MG | 1334 | Get Quote |
|
| 100MG | 1755 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAnifrolumab
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Furie R, et al. Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017 Feb;69(2):376-386.?
molnova catalog
related products
-
IFNAR-IN-1 hydrochlo...
IFNAR-IN-1 is a nonpeptidic, small molecule inhibitor of IFN-α and IFNAR interaction.
-
CP-28888
CP-28888 (CP 28888-27) is an interferon inducer, a lipoamine with antitumor activity.
-
Interferon receptor ...
Interferon receptor inducer-1 Used in the treatment of a disorder in which the induction of interferon is involved. is an interferon (IFN) receptor inducer.
